반응식
[CH3:1][O:2][C:3]1[N:8]=[C:7]2[NH:9][C:10](=[O:25])[N:11]([CH:12]3[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14][CH2:13]3)[C:6]2=[CH:5][CH:4]=1.Cl>CO.CCOCC>[CH3:1][O:2][C:3]1[N:8]=[C:7]2[NH:9][C:10](=[O:25])[N:11]([CH:12]3[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]3)[C:6]2=[CH:5][CH:4]=1참가 물질
5
실험 절차
5-Methoxy-2-oxo-1-(1-t-butoxycarbonylpiperidin-4-yl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine (100 mg, 0.287 mmol) was dissolved in methanol (2.5 mL) and a solution of 2N hydrochloric acid in ether (3 mL) was added at room temperature. After 2 h, the volatiles were removed in vacuo, to give the title compound (61 mg). MS 249.1 (M+1).
후처리
- customthe volatiles were removed in vacuo
출처 및 근거
- ORD 기록
- ord-22ad5d23d01f4d65b75809c99ab7f45c
- 출처 데이터셋
- uspto-grants-2009_05
- 특허 번호
- US07534784B2
연결된 노트
불러오는 중…